<h1 class="ql-align-justify">Corona Remedies Ltd</h1>

Corona Remedies Ltd

Corona Remedies IPO summary and company profile, product portfolio, financials and investor documents. Read the highlights.


Corona Remedies Ltd IPO Investor Facts

Corona is a high quality hyper scaler pharma company with a quality cap table of renowned Private Equity ChrisCapital holding ~26% stake, the company has consistently grown beating the industry average growth rate of 8-9%(IPM) and scaled revenue 7x and PAT 16x in the last 10 years with both organic and inorganic routes. They've also scaled the brands acquired from MNCs multifold in a very short span. The IPO is a complete OFS and the proceeds will to to existing investors and promoters selling partial stake. The IPO Ask valuation of 6,495 Cr is a bit on the higher side with ~5x P/S and 51x P/E (TTM).
Based on the current GMP of 27%, one can expect decent listing gains, provided the GMP sustains.
